BBIO
Bridgebio Pharma Inc Earnings
$51.77
Earnings Summary
Revenue | $110.57Mn |
Net Profits | $-181.9Mn |
Net Profit Margins | -164.52% |
Bridgebio Pharma Inc’s revenue jumped 4999.86% since last year same period to $110.57Mn in the Q2 2025. On a quarterly growth basis, Bridgebio Pharma Inc has generated -5.2% fall in its revenue since last 3-months.
Bridgebio Pharma Inc’s net profit fell -147.64% since last year same period to $-181.9Mn in the Q2 2025. On a quarterly growth basis, Bridgebio Pharma Inc has generated -8.65% fall in its net profits since last 3-months.
Bridgebio Pharma Inc’s net profit margin jumped 95.14% since last year same period to -164.52% in the Q2 2025. On a quarterly growth basis, Bridgebio Pharma Inc has generated -14.61% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.82 |
EPS Estimate Current Year | -0.82 |
Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current quarter stand at -0.82 - a -8.71% fall from last quarter’s estimates.
Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current year stand at -0.82.
Key Ratios
Earning Per Share (EPS) | 0 |
Bridgebio Pharma Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Bridgebio Pharma Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-05 | -0.75 | -0.95 | -26.67% |
2025-04-29 | -0.89 | -0.99 | -11.1% |
2025-10-30 | -0.82 | 0 | 100% |
